1. Andrzej Viktor "Andrew" Schally was a Polish-American endocrinologist who was a co-recipient, with Roger Guillemin and Rosalyn Sussman Yalow, of the 1977 Nobel Prize in Physiology or Medicine.
16 Facts About Andrew Schally
1. 2.
Later in life, Schally utilized his knowledge of hypothalamic hormones to research possible methods for birth control and cancer treatment.
3.
Andrzej Wiktor Andrew Schally was born in Wilno in the Second Polish Republic, the son of Brigadier General Kazimierz Andrew Schally, who was chief of the cabinet of President Ignacy Moscicki of Poland, and Maria.
4.
In September 1939, when Poland was attacked by Nazi Germany and the Soviet Union, Andrew Schally escaped with Poland's President Ignacy Moscicki, the prime minister and the whole cabinet to the neutral Romania, where they were interned.
5.
Immediately after the war, in 1945, Schally moved via Italy and France to the United Kingdom where he changed his first name to Andrew.
6.
Andrew Schally received his doctorate in endocrinology from McGill University in 1957.
7.
Andrew Schally conducted research in endocrinology at the Miami Veteran's Administration Medical Center in Miami, Florida.
8.
Andrew Schally was affiliated with the Baylor College of Medicine for some years in Houston, Texas.
9.
Andrew Schally developed a new realm of knowledge concerning the brain's control over the body chemistry.
10.
Andrew Schally's work addressed birth control methods and the effects of growth hormones on the body.
11.
Andrew Schally received an honoris causa doctors degree from the Jagiellonian University in Krakow.
12.
Andrew Schally was married to Margaret Rachel White, and Ana Maria de Medeiros-Comaru.
13.
Andrew Schally died at his home in Miami Beach, Florida, on 17 October 2024, at the age of 97.
14.
In 1981, it was demonstrated that the gonadotropin-releasing hormone agonistic analogs that Andrew Schally had developed between the years of 1972 and 1978 inhibited the growth of prostate cancer in rats.
15.
Alongside Dr George Tolis, Andrew Schally conducted the first clinical trial of GnRH for patients with advanced prostate cancer in 1982.
16.
In 2004, after the death of his wife due to thyroid cancer, Andrew Schally found comfort in continuing his research.